Biological variability and the emergence of multidrug-resistant tuberculosis.
about
Ion Channel Blockers as Antimicrobial Agents, Efflux Inhibitors, and Enhancers of Macrophage Killing Activity against Drug Resistant Mycobacterium tuberculosisA Combination Regimen Design Program Based on Pharmacodynamic Target Setting for Childhood Tuberculosis: Design Rules for the Playground.Global control of tuberculosis: from extensively drug-resistant to untreatable tuberculosisThe need to accelerate access to new drugs for multidrug-resistant tuberculosis.Differential transcriptomic and metabolic profiles of M. africanum- and M. tuberculosis-infected patients after, but not before, drug treatment.Host Immune Responses Differ between M. africanum- and M. tuberculosis-Infected Patients following Standard Anti-tuberculosis Treatment.Failure of the Amikacin, Cefoxitin, and Clarithromycin Combination Regimen for Treating Pulmonary Mycobacterium abscessus Infection.Artificial Intelligence and Amikacin Exposures Predictive of Outcomes in Multidrug-Resistant Tuberculosis Patients.Optimal Clinical Doses of Faropenem, Linezolid, and Moxifloxacin in Children With Disseminated Tuberculosis: Goldilocks.Microemulsions: Options To Expand the Synthesis of Inorganic Nanoparticles.Precursor Amino Acids Inhibit Polymyxin E Biosynthesis in Paenibacillus polymyxa, Probably by Affecting the Expression of Polymyxin E Biosynthesis-Associated GenesIsoniazid@Fe2 O3 Nanocontainers and Their Antibacterial Effect on Tuberculosis Mycobacteria.Systematic Analysis of Hollow Fiber Model of Tuberculosis Experiments.Efflux Pumps in Mycobacteria: Antimicrobial Resistance, Physiological Functions, and Role in Pathogenicity
P2860
Q28550401-F6CC7746-5CEA-4B00-9E05-A25ABCDF37FBQ30275728-2801AC78-EDA8-455C-BC76-68BD20FEB441Q33926262-C30CC280-4973-423D-8856-3C23B62B4E43Q35815071-81237897-3DF7-4DE7-8ADA-F1E8F9175E6DQ35890546-EC1BF609-24E7-4FE7-A92D-2E77AEEAE616Q36021134-6EAB433D-1687-427C-8473-EEEF1969071DQ37287641-3C6488A8-4B40-4C87-BFD6-EC9FCD82D8FCQ37287787-8326D68B-DC03-4DF5-B12A-A5367B6A3DC0Q37339290-53CE387E-8187-4135-BCAF-32800B87FA56Q39013089-07DAA64E-8248-44F8-96A3-855084551A98Q40831544-91F3E7B5-0955-4FB2-AD4C-020F06754B01Q41019979-0DA385E4-DED4-4728-9400-1F140CDF0DEEQ41082086-79849B07-6A3C-4438-95D6-6DFA0BC4EB0EQ57656351-226F1BF9-38B4-4196-8C52-E41E58960EA3
P2860
Biological variability and the emergence of multidrug-resistant tuberculosis.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
2013年學術文章
@zh
2013年學術文章
@zh-hant
name
Biological variability and the emergence of multidrug-resistant tuberculosis.
@en
Biological variability and the emergence of multidrug-resistant tuberculosis.
@nl
type
label
Biological variability and the emergence of multidrug-resistant tuberculosis.
@en
Biological variability and the emergence of multidrug-resistant tuberculosis.
@nl
prefLabel
Biological variability and the emergence of multidrug-resistant tuberculosis.
@en
Biological variability and the emergence of multidrug-resistant tuberculosis.
@nl
P2860
P356
P1433
P1476
Biological variability and the emergence of multidrug-resistant tuberculosis.
@en
P2860
P2888
P304
P356
10.1038/NG.2675
P407
P577
2013-07-01T00:00:00Z